Clinical Trial Update: Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity and safety of GlaxoSmithKline's pentavalent DTPa-HBV-IPV/Hib vaccine in Indian infants across two vaccination schedules;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• DTPa-HBV-IPV/Hib vaccine (pentavalent) (Diphtheria and tetanus toxoids, acellular pertussis, Hepatitis B, Haemophilus influenzae type b conjugate vaccine, inactivated poliovirus)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria, Acellular Pertussis | Phase 3 | Status: COMPLETED